ESC 365 - Doctor Kenneth W Mahaffey

Speaker illustration

Doctor Kenneth W Mahaffey

Stanford University Medical Center, Stanford (United States of America)

Member of:

Presentations Articles

Semaglutide and cardiovascular outcomes by baseline chronic kidney disease status and albuminuria in type 2 diabetes and chronic kidney disease: results from the FLOW trial

Event: ESC Congress 2024

Topic: Renal Failure and Cardiovascular Disease

Session: Clinical trial updates on the GLP-1 receptor agonist, semaglutide

Recognition of heart failure with micro electro-mechanical sensors using commercially available smartphone, the REFLECS study

Event: ESC Congress 2023

Topic: Mobile Apps

Session: Cutting edge digital health for early detection and efficient diagnosis

Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial

Event: ESC Congress 2022

Topic: Renal Failure and Cardiovascular Disease

Session: Renal failure and cardiovascular disease 2

Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE

Event: ESC Congress 2020

Topic: Renal Failure and Cardiovascular Disease

Session: Cardiovascular Disease in Special Populations ePosters

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources